Statements (67)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:bfsLayer |
3
|
| gptkbp:bfsParent |
gptkb:healthcare_organization
|
| gptkbp:advocates_for |
important for policy change
|
| gptkbp:affects |
gptkb:hospital
neurological disorders chronic inflammation immune system |
| gptkbp:caused_by |
gptkb:AIDS
|
| gptkbp:clinical_trial |
ongoing for new therapies
slower than HIV-1 |
| gptkbp:collaborations |
international efforts ongoing
|
| gptkbp:community_engagement |
still prevalent in many areas
|
| gptkbp:community_involvement |
important for education
|
| gptkbp:community_support |
important for mental health
beneficial for patients |
| gptkbp:current_use |
opportunistic infections
certain cancers |
| gptkbp:discovered_by |
gptkb:1986
|
| gptkbp:disease_resistance |
can develop
|
| gptkbp:duration |
lifelong
|
| gptkbp:education |
essential for management
|
| gptkbp:frequency |
recommended annually
|
| gptkbp:genetic_diversity |
lower than HIV-1
|
| gptkbp:grooming_needs |
can be undetectable
|
| gptkbp:healthcare |
varies by region
awareness access to care stigma |
| https://www.w3.org/2000/01/rdf-schema#label |
HIV-2
|
| gptkbp:is_involved_in |
helpful for coping
|
| gptkbp:is_monitored_by |
regular viral load tests
|
| gptkbp:is_popular_in |
approximately 5% of HIV cases
|
| gptkbp:is_protected_by |
regular testing
condom use Pr EP |
| gptkbp:is_tested_for |
gptkb:Western_blot
gptkb:ELISA |
| gptkbp:is_vulnerable_to |
no effective vaccine available
|
| gptkbp:origin |
West Africa
|
| gptkbp:public_awareness |
needs improvement.
|
| gptkbp:receives_funding_from |
increasing over time
|
| gptkbp:related_to |
gptkb:HIV-1
|
| gptkbp:research_focus |
vaccine development
treatment strategies |
| gptkbp:responds_to |
WHO guidelines
UNAIDS initiatives |
| gptkbp:risk_factor |
intravenous drug users
men who have sex with men heterosexuals |
| gptkbp:scholarships |
can be affected by diagnosis
|
| gptkbp:social_responsibility |
gptkb:HBV
gptkb:HCV HIV test important for protection less common than HIV-1 |
| gptkbp:symptoms |
flu-like symptoms
|
| gptkbp:transmission |
sexual contact
blood transfusion sharing needles mother to child |
| gptkbp:treatment |
gptkb:drug
critical for effectiveness c ART multiple classes of drugs |
| gptkbp:type |
gptkb:Retrovirus
|
| gptkbp:type_of |
A, B, C, D, E, F, G, H
|